Sleep Disorders Trial, Recruiting (NCT06629207)

Sleep Disorders Trial, Recruiting NCT06629207 Sponsor: Insel Gruppe AG, University Hospital Bern Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT06629207 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with a sleep condition called isolated REM Sleep Behaviour Disorder (iRBD) by a specialist in movement disorders, confirmed using recognised international sleep disorder guidelines
People who are able and willing to give written consent to take part

Who may not be able to join:

People who have already been diagnosed with Parkinson's disease or another condition that causes the brain or nervous system to break down over time
People who show clear signs of a movement disorder called parkinsonism during a physical examination
People whose REM Sleep Behaviour Disorder is linked to another sleep condition such as narcolepsy, or has another known cause
People who have moderate to severe obstructive sleep apnea (a condition where breathing repeatedly stops during sleep)
People whose neurological examination or brain scan (MRI) shows abnormal results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kuanggyu Shi, Prof. Dr. ing., University Bern, Inselspital, Center for Artificial Intelligence in Medicine

Phone: +41 316322610

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06629207

Sponsor: Insel Gruppe AG, University Hospital Bern

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: +41 316322610

More information: https://clinicaltrials.gov/study/NCT06629207

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with a sleep condition called isolated REM Sleep Behaviour Disorder (iRBD) by a specialist in movement disorders, confirmed using recognised international sleep disorder guidelines
People who are able and willing to give written consent to take part

Who may not be able to join:

People who have already been diagnosed with Parkinson's disease or another condition that causes the brain or nervous system to break down over time
People who show clear signs of a movement disorder called parkinsonism during a physical examination
People whose REM Sleep Behaviour Disorder is linked to another sleep condition such as narcolepsy, or has another known cause
People who have moderate to severe obstructive sleep apnea (a condition where breathing repeatedly stops during sleep)
People whose neurological examination or brain scan (MRI) shows abnormal results

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Insel Gruppe AG, University Hospital Bern

Registry

ClinicalTrials.gov

Start date

7 October 2024

Est. completion

1 August 2026

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Assessment of Deep Learning Model Accuracy in Predicting Neurodegenerative Conversion in isolated REM sleep behavior disorder (iRBD) through Early Biomarker Detection

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov